Earnings Wrap: Here’s How These 5 Companies Did Last Quarter

Chemicals Are Still in Demand

Although the company’s stock is off slightly in early morning trading, E I Du Pont De Nemours And Co (NYSE:DD) shareholders don’t have much to complain about today, as the chemicals giant beat EPS estimates by $0.22 with earnings per share of $1.26 as the company’s sales exceeded estimates by $230 million with revenue of $7.41 billion for the first quarter. Guidance was also high, mostly due to the weaker dollar. Management now expects fiscal year 2016 EPS to be between $3.05 and $3.20, up from the previous EPS guidance of $2.95-to-$3.10. 35 top funds that Insider Monkey tracks in its database of 786 savvy investors owned E I Du Pont De Nemours And Co (NYSE:DD) as of December 31.

Coach Reports Flat North American Comps 

Coach Inc (NYSE:COH) reported earnings of $0.44 per share on revenue of $1.03 billion, beating estimates by $0.03 per share and $10 million respectively for its third quarter of fiscal year 2016. Sales jumped by 10.8% year-over-year, in part due to the North American segment’s comparable store sales improving to flat growth after several quarters of negative growth. Guidance was for positive comparable store sales growth in North America in the fiscal fourth quarter. Coach Inc (NYSE:COH) was held by 37 top funds in our database at the end of December, up by ten from the end of September. Shares of Coach Inc are up by 1.44% this morning.

Eli Lilly Down on Earnings Miss

Eli Lilly and Co (NYSE:LLY) shares are off by around 2% out of the gate after the drug giant reported first quarter earnings of $0.83 per share on sales of $4.87 billion. Analysts were expecting $0.85 per share in earnings on $4.82 billion in revenue instead. Full year 2016 guidance was hiked to revenue expectations of $20.6 billion-to-$21.1 billion and non-GAAP EPS of $3.50-to-$3.60, up from the previous guidance of $20.2 billion-to-$20.7 billion in revenue and $3.45-to-$3.55 per share in earnings. The number of elite funds in our system with shares of Eli Lilly and Co (NYSE:LLY) rose by seven quarter-over-quarter to 54 as of the end of the fourth quarter.

Disclosure: None